Please login to the form below

Not currently logged in
Email:
Password:

Smart Thinking blog

Insights and expert advice on the key issues facing today’s pharma marketer

Change is a beast

Think about it. Change is relentless.
Change is a beast

Think about it. Change is relentless. It moves at pace and no one can tame it. Some people fear change. This may be because of familiarity – the slippers they wear that signify security and stability. The irony is that change is the only real constant. It's part of each one of us – it's in every aspect of life. 
 
Change is clearly important. It means progress and is the only way we move forward. We need to advance and grow to deal with the issues that face us in the world. Even when change does not work in our favour, it's what we do next that matters. 
 
And in healthcare, this could not be more true. Without change, we don't push any boundaries or challenge behaviour. We just keep going at the same pace. And that means patients miss out. 
 
We need to embrace change and get better health solutions to those who need them in the quickest way possible. That could be through faster diagnosis, a switch of treatment, or using gaming as a way to access information.
 
Like it or not, change is happening constantly. You can fight it, but you won't win. The competitor who accelerated change by harnessing the potential it bought could run right past you. It's time to confront the fear and venture into the unknown, safe in the knowledge that you'll be guided and supported by someone who can shed light on the adventure ahead. The secret is finding the right guide for you. 


Article by
Craig Mills and Kristina Marshall

Craig is Leader of Accelerated Change and Kristina is a writer guru

21st November 2016

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cegedim Health Data

Cegedim Health Data provides Real World Data and Evidence services to enable advancements in patient outcomes. With a data history...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...